A Clinical Study of Pediatric Myelodysplastic Syndrome: Application of International Prognostic Scoring System and the Review of the Korean Literature.
- Author:
Hoon KOOK
1
;
Chan Jong KIM
;
Weon Sang YOON
;
Na Eun RYU
;
Kyoung Joong CHUNG
;
Tai Ju HWANG
Author Information
1. Department of Pediatrics, Chonnam University Medical School, Kwangju, Korea.
- Publication Type:Original Article
- Keywords:
Myelodysplastic syndrome;
Children;
Acute myelogenous leukemia;
Survi- val;
Prognosis;
Scoring system
- MeSH:
Child;
Classification;
Consensus;
Humans;
Jeollanam-do;
Korea;
Leukemia, Myeloid, Acute;
Myelodysplastic Syndromes*;
Natural History;
Prognosis;
Sex Ratio
- From:Journal of the Korean Cancer Association
2000;32(1):178-190
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Myelodysplastic syndrome (MDS) in children needs to be elucidated in terms of clinical characteristics, natural history, the most effective treatment and prognostic factors, as the disease is very rare and its definition and classification has not reached a consensus by many physician. This study was aimed to describe the characteristics and the disease courses of Korean children with MDS, and to analyze the usefulness of prognostic scoring systems in the prediction of transformation to acute myelogenous leukemia (AML) and overall survival among subgroups. MATERIALS AND METHODS: Fourteen children with MDS seen at Chonnam University Hospital and additional 59 patients identified by the review of Korean literature were evaluated to define clinical characteristics and disease courses. Kaplan-Meier (K-M) probability of leukemic transformation and overall survival were plotted. FAB subtypes, subgroups by Boumemouth Scoring System (BSS), and International Prognostic Scoring System (IPSS) risk groups were compared to predict transformation to AML and overall survival. RESULTS: The median age of 14 patients was 36.5 months. The sex ratio was 3.7:1 (M: F). The frequency of FAB subtypes in Korea was similar to that of other countries except for higher proportion of RA (37%). K-M 3-yr probability of AML transformation and survival for Korean patients were 54.7%, and 49.8%, respectively. Although FAB system, BMS and IPSS were all capable of discriminating subgroups in the prediction of AML transformation and survival, they did not reach the significant level possibly due to small number of patients assigned to each subgroup. CONCLUSION: The clinical characteristics of Korean children with MDS were not different from those of other countries. This study showed the high rate of AML transformation and poor survival in children with MDS.
